Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lukas J Lehner

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Endocrinology, Diabetes & Metabolism Case Reports|December 19, 2014
Glucagonoma-induced acute heart failureKun Zhang, Lukas J Lehner, Damaris Praeger, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 11, 2018
Validation of the Living Kidney Donor Profile Index in a European cohort and comparison of long-term outcomes with US resultsGregor Rehse, Fabian Halleck, Dmytro Khadzhynov, et al.
Clinical Transplantation|October 21, 2017
Evaluation of adherence and tolerability of prolonged-release tacrolimus (Advagraf™) in kidney transplant patients in Germany: A multicenter, noninterventional studyLukas J Lehner, Petra Reinke, Jan H Hörstrup, et al.
Current Reviews in Clinical and Experimental Pharmacology|February 16, 2021
STABIL-study: The Course of Therapy, Safety and Pharmacokinetic Parameters of Conversion of Prograf® to Tacrolimus HEXAL®/Crilomus® in Renal Transplant Recipients - an Observational Study in GermanyLukas J Lehner, Klaus Kalb, Karl Weigand, et al.
Journal of Clinical Medicine|September 5, 2020
Analysis of Risk Factors and Long-Term Outcomes in Kidney Transplant Patients with Identified LymphocelesLukas J Lehner, Arnim Hohberger, Lisanne Marschke, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 19, 2021
Evaluation of severity of delayed graft function in kidney transplant recipientsEva Schrezenmeier, Mia Müller, Frank Friedersdorff, et al.
Journal of Critical Care|November 12, 2021
Efficacy and complications of regional citrate anticoagulation during continuous renal replacement therapy in critically ill patients with COVID-19Dmytro Khadzhynov, Uwe von dem Berge, Frédéric Muench, et al.
Research and Reports in Urology|July 21, 2021
Focal Segmental Glomerulosclerosis and Recurrence in Living Donor RecipientsJosef Mang, Linda Hennig, Lutz Liefeldt, et al.
Transplantation|June 29, 2017
Pharmacokinetics and Clinical Outcomes of Generic Tacrolimus (Hexal) Versus Branded Tacrolimus in De Novo Kidney Transplant Patients: A Multicenter, Randomized TrialWolfgang Arns, Andrea Huppertz, Thomas Rath, et al.
BMC Nephrology|February 6, 2019
A prospective study of daclatasvir and sofosbuvir in chronic HCV-infected kidney transplant recipientsMichael Duerr, Eva V Schrezenmeier, Lukas J Lehner, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Endocrinology, Diabetes & Metabolism Case Reports|December 19, 2014
Glucagonoma-induced acute heart failureKun Zhang, Lukas J Lehner, Damaris Praeger, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 11, 2018
Validation of the Living Kidney Donor Profile Index in a European cohort and comparison of long-term outcomes with US resultsGregor Rehse, Fabian Halleck, Dmytro Khadzhynov, et al.
Clinical Transplantation|October 21, 2017
Evaluation of adherence and tolerability of prolonged-release tacrolimus (Advagraf™) in kidney transplant patients in Germany: A multicenter, noninterventional studyLukas J Lehner, Petra Reinke, Jan H Hörstrup, et al.
Current Reviews in Clinical and Experimental Pharmacology|February 16, 2021
STABIL-study: The Course of Therapy, Safety and Pharmacokinetic Parameters of Conversion of Prograf® to Tacrolimus HEXAL®/Crilomus® in Renal Transplant Recipients - an Observational Study in GermanyLukas J Lehner, Klaus Kalb, Karl Weigand, et al.
Journal of Clinical Medicine|September 5, 2020
Analysis of Risk Factors and Long-Term Outcomes in Kidney Transplant Patients with Identified LymphocelesLukas J Lehner, Arnim Hohberger, Lisanne Marschke, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 19, 2021
Evaluation of severity of delayed graft function in kidney transplant recipientsEva Schrezenmeier, Mia Müller, Frank Friedersdorff, et al.
Journal of Critical Care|November 12, 2021
Efficacy and complications of regional citrate anticoagulation during continuous renal replacement therapy in critically ill patients with COVID-19Dmytro Khadzhynov, Uwe von dem Berge, Frédéric Muench, et al.
Research and Reports in Urology|July 21, 2021
Focal Segmental Glomerulosclerosis and Recurrence in Living Donor RecipientsJosef Mang, Linda Hennig, Lutz Liefeldt, et al.
Transplantation|June 29, 2017
Pharmacokinetics and Clinical Outcomes of Generic Tacrolimus (Hexal) Versus Branded Tacrolimus in De Novo Kidney Transplant Patients: A Multicenter, Randomized TrialWolfgang Arns, Andrea Huppertz, Thomas Rath, et al.
BMC Nephrology|February 6, 2019
A prospective study of daclatasvir and sofosbuvir in chronic HCV-infected kidney transplant recipientsMichael Duerr, Eva V Schrezenmeier, Lukas J Lehner, et al.
Pageof 2